Considerations for Treating Locally Advanced NSCLC

Video

Considerations for Treating Locally Advanced NSCLC

A 60-year-old Asian Woman With Unresectable, Locally Advanced NSCLC

  • A 60-year-old Asian woman presents with complaints of chest pain and shortness of breath. She reports developing a persistent cough about 1 year ago, which she attributed to allergies. In the past month, she has “spit up” blood several times, which caused her to make the appointment.
  • Her history includes:
    • Former smoker, quit smoking at age 35 when she became pregnant
    • Normal BMI, postmenopausal, no history of cardiovascular disease
    • No previous cancer history
  • Evaluation and follow up testing reveal
    • Stage IIIA NSCLC in right bronchi: 3.5-cm tumor with pleural involvement and spread to mediastinal lymph nodes
    • WHO performance status 1
    • Histology: Squamous cell
    • Biomarkers:
      • EGFR,BRAF,ALK/ROS1negative
      • PD-L1 status: 10%
  • After multidisciplinary evaluation, the patient was determined not to be a candidate for surgery, and completed chemoradiotherapy:
    • Carboplatin/paclitaxel doublet plus 55 Gy radiotherapy
    • Achieved stable disease without progression 14 days after completing treatment
    • Began treatment with durvalumab
Related Videos
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Related Content